Samuel Kintz - PRESIDENT AND CEO, Director at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Stock Symbol
ELVN on Nasdaq, IMRA on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Samuel Kintz - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Samuel Kintz for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 890K $19.4M $21.82 Nov 17, 2025 Indirect
Stock Option (right to buy) 490K Feb 6, 2025 Direct Common Stock

Transactions reported by Samuel Kintz for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.